Lung Cancer Patients Have Lower Antibody Response to COVID-19 Vaccination
Researchers are evaluating whether specific anticancer therapies affect antibody levels.
Researchers are evaluating whether specific anticancer therapies affect antibody levels.
Vaccinated individuals who tested positive for SARS-CoV-2 were more likely to be completely asymptomatic.
About 98% of patients from the highly allergic group had no immediate allergic event after the first dose of the BNT162b2 vaccine.
NCCN guidance says several groups should be considered eligible immediately for a third dose of either of the mRNA vaccines.
Reasons why doses may be marked as wasted include a cracked vial, an error diluting the vaccine, a freezer malfunction.
COVID-19 vaccine hesitancy was higher among Black, Hispanic/Latino, and Asian health care workers (HCWs) compared with White HCWs.
Hospitalization rates among fully vaccinated people were higher among older residents of nursing homes and among those with underlying conditions.
Patients with active multiple myeloma may have insufficient responses to mRNA COVID-19 vaccines.
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Vaccination was not associated with an elevated risk for most of the adverse events examined.